Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.
Levasseur
Régis
R
Dargent-Molina
Patricia
P
Sabatier
Jean-Pierre
JP
Marcelli
Christian
C
Bréart
Gérard
G
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D005602:France; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control*; D011446:Prospective Studies; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists